CAMBRIDGE, Mass.--(BUSINESS WIRE)--Omega Therapeutics™, a company pioneering a new category of genomic medicine through epigenomic programming, today announced the completion of an $85 million ...

GC Therapeutics Launches to Scale and Unlock the Next Generation of Cell Therapy TFome™, the world’s first “plug-and-play” iPSC cellular programming platform, streamlines development and accelerates ...

The earliest days after fertilization, once a sperm cell meets an egg, are shrouded in scientific mystery. The process of how a humble single cell becomes an organism fascinates scientists across ...